Jacobs Levy Equity Management, Inc Fortress Biotech, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$21.8 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.8 - $1.5 $351,117 - $658,345	-438,897 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.24 - $2.75 $409 - $907	-330 Reduced 0.08%	438,897 $597,000
Q4 2021 Feb 14, 2022	BUY	$2.42 - $3.65 $1.06 Million - $1.6 Million	439,227 New	439,227 $1.1 Million
Q3 2021 Nov 15, 2021	SELL	$2.82 - $3.7 $69,397 - $91,053	-24,609 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.5 - $5.48 $10,349 - $16,204	-2,957 Reduced 10.73%	24,609 $88,000

Q1 2021 May 17, 2021	BUY	$3.16 - $4.89 $52,203 - $80,782	16,520 Added 149.56%	27,566 $97,000
Q4 2020 Feb 16, 2021	SELL	$2.2 - $4.45 $279,085 - $564,513	-126,857 Reduced 91.99%	11,046 $35,000
Q3 2020 Nov 16, 2020	SELL	$2.62 - $4.78 $7,000 - $12,772	-2,672 Reduced 1.9%	137,903 $557,000
Q2 2020 Aug 17, 2020	BUY	$1.83 - $3.16 $79,559 - $137,381	43,475 Added 44.77%	140,575 $377,000
Q3 2019 Nov 14, 2019	SELL	$1.26 - $1.96 $36,289 - $56,449	-28,801 Reduced 22.88%	97,100 $137,000
Q1 2019 May 14, 2019	SELL	$0.94 - $2.47 $164,580 - $432,462	-175,086 Reduced 58.17%	125,901 $224,000
Q4 2018 Feb 14, 2019	BUY	$0.57 - $1.53 $51,189 - $137,403	89,806 Added 42.53%	300,987 $259,000
Q3 2018 Nov 14, 2018	BUY	$1.44 - $3.13 $112,963 - $245,539	78,447 Added 59.1%	211,181 $338,000
Q2 2018 Aug 14, 2018	BUY	$2.92 - $5.1 $241,086 - $421,076	82,564 Added 164.57%	132,734 $396,000
Q1 2018 May 15, 2018	SELL	$3.42 - $5.35 $136,800 - $214,000	-40,000 Reduced 44.36%	50,170 $228,000
Q4 2017 Feb 13, 2018	BUY	$3.26 - $4.84 $180,180 - $267,506	55,270 Added 158.37%	90,170 $360,000
Q3 2017 Nov 14, 2017	BUY	$3.83 - $4.89 $133,667 - $170,661	34,900	34,900 $154,000

Others Institutions Holding FBIO

# of Institutions

Shares Held

1.01M

Call Options Held

Put Options Held

View Full List

About Fortress Biotech, Inc.

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

More about FBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account